The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

MAQC Consortium·2010·Nature Biotechnology
DOI 10.1038/nbt.1665

Cited by (894)

Items 601–700 of 894

  1. Explore the dynamic alternation of gene PLAC4 mRNA expression levels in maternal plasma in second trimester for nonivasive detection of trisomy 21
    Lan Yang, Hai-Yan Sun, Dao-Zhen Chen, Mu-Dan Lu, Ye Tang, Jian-Pin Xiao · 2015 · Obstetrics & Gynecology Science
  2. Plasma pTau181 enhances the prediction of future clinical decline in amyloid‐positive mild cognitive impairment
    Viswanath Devanarayan, Daniel A. Llano, Yan Helen Hu, Harald Juergen Hampel, Lynn Darden Kramer, Shobha Dhadda, Michael C. Irizarry · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  3. sbv IMPROVER Diagnostic Signature Challenge
    Raquel Norel, Erhan Bilal, Nathalie Conrad-Chemineau, Richard Bonneau, Alberto de la Fuente, Igor Jurišica, Daniel Marbach, Pablo Meyer, John Jeremy Rice, Tamir Tuller et al. · 2013 · Systems Biomedicine
  4. D-trace estimation of a precision matrix using adaptive Lasso penalties
    Vahe Avagyan, Andrés M. Alonso, Francisco J. Nogales · 2016 · Advances in Data Analysis and Classification
  5. High expression of CPNE5 and CPNE9 predicts positive prognosis in multiple myeloma
    Pei Zhu, Tingting Qian, Chaozeng Si, Yan Liu, Longzhen Cui, Wenhui Huang, Lin Na Fu, Cong Deng, Tiansheng Zeng · 2021 · Cancer Biomarkers
  6. The role of statistics in the design and analysis of companion diagnostic (CDx) studies
    Gregory Campbell · 2021 · Biostatistics & Epidemiology
  7. Deep learning-based detection and identification of brain tumor biomarkers in quantitative MR-images
    Iulian Emil Tampu, Neda Haj‐Hosseini, Ida Blystad, Anders Eklund · 2023 · Machine Learning Science and Technology
  8. Biomarkers of tolerance: searching for the hidden phenotype
    Esperanza Perucha, Irene Rebollo‐Mesa, Pervinder Sagoo, María P. Hernández-Fuentes · 2011 · Kidney International Supplements
  9. PI3K-based molecular signatures link high PI3K pathway activity with low ER levels in ER + breast cancer
    Álex Sánchez‐Pla, Josep Villanueva · 2010 · Expert Review of Proteomics
  10. Robust meta-analysis shows that glioma transcriptional subtyping complements traditional approaches
    Sanghoon Lee, Stephen Piccolo, Kristina Allen‐Brady · 2014 · Cellular Oncology
  11. Credentialing Individual Samples for Proteogenomic Analysis
    Wei Zhao, Jun Li, Rehan Akbani, Han Liang, Gordon Brent Mills · 2018 · Molecular & Cellular Proteomics
  12. High expression of CHML predicts poor prognosis of multiple myeloma
    Weilong Zhang, Ling Cao, Xiaoni Liu, Xue He, Ye Zhang, Zuozhen Yang, Ping Yang, Jing Wang, Kai Hu, Xiuru Zhang et al. · 2019 · Journal of Cancer
  13. Family Rank: a graphical domain knowledge informed feature ranking algorithm
    Michelle Edelman Saul, Valentin Dinu · 2021 · Bioinformatics
  14. A systematic review of datasets that can help elucidate relationships among gene expression, race, and immunohistochemistry-defined subtypes in breast cancer
    Ifeanyichukwu O. Nwosu, Stephen Piccolo · 2021 · Cancer Biology & Therapy
  15. Genome-wide gene expression analysis reveals molecular insights into the drug-induced toxicity of nephrotoxic agents
    Nguyen Thi Hai Yen, Se‐Myo Park, Vo Thuy Anh Thu, Nguyen Ky Phat, Yong‐Soon Cho, Seokjoo Yoon, Jae‐Gook Shin, Dong‐Hyun Kim, Jung‐Hwa Oh, Nguyen Phuoc Long · 2022 · Life Sciences
  16. Machine Learning and Non-Investment Crowdfunding Research: A Tutorial
    Ramy Elitzur · 2023 · Journal of Alternative Finance
  17. Quality Visualization of Microarray Datasets Using Circos
    Martin Koch, Michael Wiese · 2012 · Microarrays
  18. New opportunity for Chinese pharmaceutical R & D: systematic drug repurposing based on big data
    Kejian Wang, Yongxiang Zhang, Leming M. Shi, Lin He, Lun Yang · 2014 · Chinese Science Bulletin (Chinese Version)
  19. Microarray Inspector: tissue cross contamination detection tool for microarray data.
    Piotr Stępniak, Matthew Maycock, Konrad Wojdan, Monika Markowska, Serhiy Perun, Aashish Srivastava, Lucjan Stanislaw Wyrwicz, Konrad Świrski · 1970 · Acta Biochimica Polonica
  20. Nonnegative matrix factorization for the improvement in sensitivity of discovering potentially disease-related genes
    Juan Zhang, Lifang Zhang, Gang Yang, Di Wu, Lina Jiang, Liqiu Huang, Zhining Wen, Menglong Li · 2013 · Chemometrics and Intelligent Laboratory Systems
  21. Discovering Pair-wise Synergies in Microarray Data
    Yuan Chen, Dan Cao, Jun Gao, Zheming Yuan · 2016 · Scientific Reports
  22. Embracing noise to improve cross-batch prediction accuracy
    Chuan Hock Koh, Limsoon Wong · 2012 · BMC Systems Biology
  23. Improving interpretation by orthogonal variation : Multivariate analysis of spectroscopic data
    Hans C. Stenlund · 2011 · DiVA at Umeå University (Umeå University)
  24. A Monocyte-Driven Prognostic Model for Multiple Myeloma: Multi-Omics and Machine Learning Insights
    Linzhi Xie, Meng Gao, Shiming Tan, Yi Zhou, Jing Liu, Liwen Wang, Xin Li · 2025 · Blood and Lymphatic Cancer Targets and Therapy
  25. Identification of Under-Detected Periodicity in Time-Series Microarray Data by Using Empirical Mode Decomposition
    Chaang-Ray Chen, Wun‐Yi Shu, Cheng-Wei Chang, Ian C. Hsu · 2014 · PLoS ONE
  26. TP53 Signature Can Predict Pathological Response From Neoadjuvant Chemotherapy and Is a Prognostic Factor in Patients With Residual Disease
    Shinʼ ichi Takahashi, Keiju Sasaki, Chikashi Ishioka · 2023 · Breast Cancer Basic and Clinical Research
  27. AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis
    Babak Oskouian, Joanna Y. Lee, Shahab Asgharzadeh, Ranjha Khan, Meng Zhang, Julia R. Weisbrod, YounJeong Choi, Latika Puri, Ana E. Aguilar, Piming Zhao et al. · 2024 · Oncogene
  28. Identifying high‐risk multiple myeloma patients: A novel approach using a clonal gene signature
    Jianrong Li, Christiana Wang, Chao Cheng · 2024 · International Journal of Cancer
  29. Perinuclear compartment controls calcineurin/MEF2 signaling for axonal outgrowth of hippocampal neurons
    Joanna Mackiewicz, Malwina Lisek, Julia Tomczak, Agata Sakowicz, Feng Guo, Tomasz Boczek · 2024 · Frontiers in Molecular Neuroscience
  30. Genetics of Renal Tumors
    Ryoiti Kiyama, Yun Zhu, Teiichiro Aoyagi · 2013 · InTech eBooks
  31. A predictive microarray-based biomarker for early detection of Alzheimer’s disease intended for clinical diagnostic application
    Margaret A. Calciano, Jean Christophe Lemarié, Elodie Blondiaux, Richard Einstein, Pascale Fehlbaum · 2013 · Biomarkers
  32. Optimistic bias in the assessment of high dimensional classifiers with a limited dataset
    Weijie Chen, David G. Brown · 2011 · International Joint Conference on Neural Networks (IJCNN)
  33. Statistical modeling for differential transcriptome analysis using RNA-Seq technology
    Jeffrey C. Miecznikowski, Song Liu, Xing Ren · 2012 · Journal of Solid Tumors
  34. Response to “Incorporating Biological, Chemical, and Toxicological Knowledge Into Predictive Models of Toxicity”
    Russell S. Thomas, Michael B. Black, Lili Li, Eric Healy, Tzu‐Ming Chu, Wenjun Bao, Melvin E. Andersen, Russell D. Wolfinger · 2012 · Toxicological Sciences
  35. Prognostic Models for Breast Cancer Systematic Analysis of Challenge-Driven Improvements in Molecular
    Adam A. Margolin · 2013
  36. Novel Computational Identification of Highly Selective Biomarkers of Pollutant Exposure
    David Weisman, Hong Liu, Jessica Redfern, Liya Zhu, Adán Colón‐Carmona · 2011 · Environmental Science & Technology
  37. CGDM: collaborative genomic data model for molecular profiling data using NoSQL
    Shicai Wang, Mihaela A. Mares, Yike Guo · 2016 · Bioinformatics
  38. The effects of sample size on omics study: from the perspective of robustness and diagnostic accuracy
    Xiaoyu Zhang, Xuejiao Cui, Feng Zhu · 2019 · IOP Conference Series Earth and Environmental Science
  39. Application of clinical nomograms to predicting overall survival and event-free survival in multiple myeloma patients: Visualization tools for prognostic stratification
    Jiaxuan Xu, Yifan Zuo, Jingjing Sun, Min Zhou, Xiaoqing Dong, Bing Chen · 2022 · Frontiers in Public Health
  40. A Generalized Non-Linear Model Predicting the Efficacy of Neoadjuvant Therapy in HER Positive Breast Cancer: Based on Tumor Immune Infiltration Phenotype
    Yusong Wang, Xiaoyan Liu, Ke‐Da Yu, Shouping Xu, Pengfei Qiu, Xinwen Zhang, Mozhi Wang, Yingying Xu · 2022 · iScience
  41. FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma
    Weilong Zhang, Chaoling Wu, Shuang Geng, Jing Wang, Changjian Yan, Xiannian Zhang, Jiajia Zhang, Fan Wu, Yuhong Pang, Yuping Zhong et al. · 2023 · Aging
  42. Transcriptome Analysis of Adrenocortical Cells in Health and Disease
    Tomohiro Ishii · 2014 · Elsevier eBooks
  43. High expression of nucleoporin 133 mRNA in bone marrow CD138+ cells is a poor prognostic factor in multiple myeloma
    Soushi Ibata, Masayoshi Kobune, Shohei Kikuchi, Masahiro Yoshida, Shogo Miura, Hiroto Horiguchi, Kazuyuki Murase, Satoshi Iyama, Kohichi Takada, Koji Miyanishi et al. · 2018 · Oncotarget
  44. Meta-analysis of gene expression for development and validation of a diagnostic biomarker panel for Oral Squamous Cell Carcinoma
    Vladimir Makarov, Alex Gorlin · 2019 · Computational Biology and Chemistry
  45. Clinical implementation of RNA signatures for pharmacogenomic decision-making
    Margaret L. Gulley, Tang, Zhiyuan Hu, Muallem, Margaret L. Gulley · 2011 · Pharmacogenomics and Personalized Medicine
  46. Confident Predictability: Identifying reliable gene expression patterns for individualized tumor classification using a local minimax kernel algorithm
    Lee Kenneth Jones, Fei Zou, Alexander Kheifets, Konstantin Rybnikov, Damon Berry, Aik Choon Tan · 2011 · BMC Medical Genomics
  47. Regulatory Considerations for Clinical Mass Spectrometry: Multiple Reaction Monitoring
    Emily S. Boja, Henry Rodriguez · 2011 · Clinics in Laboratory Medicine
  48. Bioinformatic Resources for Diabetic Nephropathy
    Amy Jayne McKnight, Alexander Peter Maxwell · 2013 · Journal of Bioinformatics and Diabetes
  49. ADME Processes in Vaccines and PK/PD Approaches for Vaccination Optimization
    José David Gómez‐Mantilla, Iñaki F. Trocóniz, Marı́a J. Garrido · 2015 · Pharmaceutical Sciences Encyclopedia
  50. Multi-Platform Assessment of DNA Sequencing Performance using Human and Bacterial Reference Genomes in the ABRF Next-Generation Sequencing Study
    Jonathan Foox, Scott W. Tighe, Charles M. Nicolet, Justin M. Zook, Marta S. Byrska‐Bishop, Wayne E. Clarke, Michael M. Khayat, Medhat Mahmoud, Phoebe K. Laaguiby, Zachary T. Herbert et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Development of Clinical-Radiomics Nomogram for Predicting Post-Surgery Functional Improvement in High-Grade Glioma Patients
    Tamara Ius, Maurizio Polano, Michele Dal Bo, Daniele Bagatto, Valeria Bertani, Davide Gentilini, Giuseppe Lombardi, Serena D’Agostini, Miran Škrap, Giuseppe Toffoli · 2025 · Cancers
  52. Individualized dynamic risk assessment and treatment selection for multiple myeloma
    Carl Murie, Serdar Turkarslan, Anoop P. Patel, David Glen Coffey, Pamela Sue Becker, Nitin S. Baliga · 2025 · British Journal of Cancer
  53. A unified generalization of the inverse regression methods via column selection
    Yin Jin, Wei Luo · 2025 · Journal of the Royal Statistical Society Series B (Statistical Methodology)
  54. High PARP1 expression is associated with proliferative tumor biology in breast cancer
    Farhad Ghasemi, Jun Arima, Kazuaki Takabe · 2025 · Breast Cancer Research and Treatment
  55. Quality control for a large‐scale study using protein arrays and protein beads to measure immune response in serum and plasma
    Neha Ghevaria, Matthieu Visser, Ralf Hoffmann · 2012 · PROTEOMICS
  56. Big data in drug design
    Ling WANG, Jun Xu, Chenzhong Liao, Xin YAN, P. Ding, Zhihong Liu, Qiong Gu · 2015 · Chinese Science Bulletin (Chinese Version)
  57. Fufang E’jiao Jiang’s effect on immunity, hematopoiesis, and angiogenesis via a systematic “compound-effect-target” analysis
    Xiang Li, Xiao Li Xu, Ying Dong, Shusheng Fan, Xueyang Ren, Yuan Zheng, Jiamu Ma, Feng Zhang, Qingyue Deng, Xianxian Li et al. · 2023 · Food Science and Human Wellness
  58. Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma
    Priya Choudhry, Corynn Kasap, Bonell Patiño-Escobar, Olivia Gugliemini, Huimin Geng, Vishesh Sarin, Amrik S. Kang, Audrey Kishishita, Sham Rampersaud, Letitia Sarah et al. · 2024 · Blood Neoplasia
  59. Characterization of driver mutations identifies gene signatures predictive of prognosis and treatment sensitivity in multiple myeloma
    Jianrong Li, Abinand Krishna Parthasarathy, Aravind Singaram Kannappan, Shahram Arsang‐Jang, Jing Dong, Chao Cheng · 2024 · The Oncologist
  60. Predicting mental health treatment outcomes using latent growth mixture models and machine learning in a real-world clinical setting
    Lee Lancashire, Steven Lloyd Lancaster, David J. Linkh, Anthony M. Hassan, Magali Haas, Allyson T. Gage · 2024 · Journal of Psychiatric Research
  61. Human blood gene signature as a marker for smoking exposure: Computational approaches of the top ranked teams in the sbv IMPROVER Systems Toxicology challenge
    Adi Laurentiu Tarca, Xiaofeng Gong, Roberto J. Romero, Wenxin Yang, Zhongqu Duan, Hao Yang, Chengfang Zhang, Peixuan Wang · 2017 · Computational Toxicology
  62. Improving Model Performance on the Stratification of Breast Cancer Patients by Integrating Multiscale Genomic Features
    Yingyi Hao, Li Fang He, Yifan Zhou, Yiru Chen Zhao, Menglong Li, Runyu Jing, Zhining Wen · 2020 · BioMed Research International
  63. A mutation in negative regulator of basal resistance WRKY17 of Arabidopsis increases susceptibility to Agrobacterium-mediated transient genetic transformation
    Benoît Lacroix, Vitaly Citovsky · 2013 · F1000Research
  64. Perturbation of Wnt/β‐catenin signaling and sexual dimorphism in non‐alcoholic fatty liver disease
    Matthew M. Yeh, Xiuhui Shi, Jingxuan Yang, Min Li, Kar-Ming A. Fung, Sayed S. Daoud · 2022 · Hepatology Research
  65. Artificial Intelligence in Blood Transcriptomics
    Stefanie Warnat‐Herresthal, Marie Oestreich, Joachim Ludwig Schultze, Matthias Becker · 2022 · Springer eBooks
  66. What Is the Transcriptome and How It Is Evaluated
    Amanda F. Assis, Ernna Hérida Domingues de Oliveira, Paula Barbim Donate, Silvana Giuliatti, Catherine Nguyen, Geraldo Aleixo Silva Passos · 2022 · Springer eBooks
  67. Identification of potential target genes of breast cancer in response to Chidamide treatment
    Han Han, Xue Feng, Yarui Guo, Meijia Cheng, Zheng‐Guo Cui, Shanchun Guo, Weiqiang Zhou · 2022 · Frontiers in Molecular Biosciences
  68. A new autophagy-related nomogram and mechanism in multiple myeloma
    Han-Ying Huang, Yang Li, Ziang Zhu, Yang Liu, Weida Wang, Shuzhao Chen, Xiaoping Wu, Yun Wang, Yanzhou Chen, Huan‐Xin Lin et al. · 2023 · Genes & Diseases
  69. Evaluating the three-level approach of the U-smile method for imbalanced binary classification
    Barbara Więckowska, Katarzyna B. Kubiak, Przemysław Guzik · 2025 · PLoS ONE
  70. Finding causative genes from high-dimensional data: an appraisal of statistical and machine learning approaches
    Chamont Wang, Jana L. Gevertz · 2016 · Statistical Applications in Genetics and Molecular Biology
  71. Education's Complexity in the Context of Human Development
    Myriam Patricia Cifuentes, Soledad Fernández · 2016 · Systems Research and Behavioral Science
  72. Breast Cancer Genomics
    Birendra Kumar · 2014 · Springer eBooks
  73. Win percentage: a novel measure for assessing the suitability of machine classifiers for biological problems
    R. Mitchell Parry, John H. Phan, May Dongmei Wang · 2012 · BMC Bioinformatics
  74. Molecular profiling contributes more than routine histology and immonohistochemistry to breast cancer diagnostics
    Christine Y. Shiang, Lajos Pusztai · 2010 · Breast Cancer Research
  75. A Machine Learning Pipeline for Identification of Discriminant Pathways
    Annalisa Barla, Giuseppe Jurman, Roberto Visintainer, Margherita Squillario, Michele Filosi, Samantha Riccadonna, Cesare Furlanello · 2013 · Springer eBooks
  76. A standardized fold change method for microarray differential expression analysis used to reveal genes involved in acute rejection in murine allograft models
    Weichen Zhou, Yi Wang, Masayuki Fujino, Leming M. Shi, Jin Li, Xiao‐Kang Li, Jiucun Wang · 2017 · FEBS Open Bio
  77. Quadratic Majorization for Nonconvex Loss with Applications to the Boosting Algorithm
    Zhu Wang · 2018 · Journal of Computational and Graphical Statistics
  78. Omics Biomarkers in Risk Assessment
    Hong Fang, Huixiao Hong, Zhichao Liu, Roger Perkins, Reagan J. Kelly, John Beresney, Weida Tong, Bruce A. Fowler · 2013 · Elsevier eBooks
  79. microRNA Profiling: Strategies and Challenges
    Jiekun Xuan, Leming M. Shi, Lei Guo · 2013 · Wiley eBooks
  80. False discovery rate control for identifying simultaneous signals
    Sihai Dave Zhao · 2015 · arXiv (Cornell University)
  81. Using cell line and patient samples to improve predictions of patient drug response
    Cheng Zhao, Ying Li, Zhaleh Safikhani, Benjamin Haibe‐Kains, Anna Goldenberg · 2015 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Individualized dynamic risk assessment for multiple myeloma
    Carl Murie, Serdar Turkarslan, Anoop P. Patel, David Glen Coffey, Pamela Sue Becker, Nitin S. Baliga · 2024 · medRxiv
  83. Autophagy-related genes affect the survival of multiple myeloma patients depending on chromosomal abnormality
    Gizem Ayna Duran, Yasemin Benderli Cihan · 2022 · Asian Biomedicine
  84. Epirubicin Induces Cell Cycle Arrest in Multiple Myeloma Cells by Downregulating CDC20 Expression
    Zhen Nan, Xueting Wang, Yaomei Wang, Yushan Cui, Baijun Fang · 2025 · Frontiers in Bioscience-Landmark
  85. Analysis of DNA Microarrays
    Shigeyuki Matsui, Hisashi Noma · 2012 · Chapman & Hall/CRC eBooks
  86. Computational Methods for Mass Spectrometry Imaging: Challenges, Progress, and Opportunities
    Chanchala D. Kaddi, May Dongmei Wang · 2017 · Health information science
  87. PERform: assessing model performance with predictivity and explainability readiness formula
    Leihong Wu, Joshua Xu, Weida Tong · 2024 · Journal of Environmental Science and Health Part C
  88. Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene Expression
    Denis J. Ohlstrom, Zachary J. Walker, Abhishek Pandey, Lorraine N. Davis, Krysta L. Engel, Zenggang Pan, Peter A. Forsberg, Tomer Martin Mark, Austin E. Gillen, Daniel W. Sherbenou · 2024 · Cancer Research Communications
  89. Identifying potential prognosis markers in relapsed multiple myeloma via integrated bioinformatics analysis and biological experiments
    Yong Xu, Xinya Cao, He Zhou, Xu Han, Bing Chen, Hua Bai · 2025 · Current Research in Translational Medicine
  90. Downregulated expression of dual-specificity phosphatase-1 in multiple myeloma as a predictor of poor survival outcomes
    Dan Guo, Jinfeng Lu, Lemin Hong, Hong Liu, Hongming Huang · 2025 · Hematology
  91. System Theoretic Methods in Drug Discovery and Vaccine Formulation: Review and Perspectives
    Ankita Sharma, Yen-Che Hsiao, Abhishek Dutta · 2025 · Drugs and Drug Candidates
  92. Experimental analysis of feature selection stability for high-dimension and low-sample size gene expression classification task
    David Dernoncourt, Blaise Hanczar, Jean‐Daniel Zucker · 2012 · IEEE International Conference on Bioinformatics and Bioengineering (BIBE)
  93. Toxicogenomics – A Drug Development Perspective
    Yuping Wang, Jürgen T. Borlak, Weida Tong · 2013 · Elsevier eBooks
  94. Feature extraction via composite scoring and voting in breast cancer
    Martin Koch, Markus Hanl, Michael Wiese · 2012 · Breast Cancer Research and Treatment
  95. omniClassifier
    John H. Phan, Sonal Kothari, May Dongmei Wang · 2014 · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB)
  96. Marker der Immunantwort bei Organtransplantation
    Jan Henrik Beckmann, Nils Heits, Felix Braun, Tobias Becker · 2013 · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie
  97. Comparing the Expected Misclassification Cost for Two Classifiers Based on Estimates From the Same Sample
    James F. Troendle, Kai Fun Yu, Peter H. Westfall, Gene A. Pennello, Enrique F. Schisterman · 2012 · Statistics in Biopharmaceutical Research
  98. Novel calibration tools and validation concepts for microarray-based platforms used in molecular diagnostics and food safety control
    C. Brunner, Katrin Hoffmann, T. Thiele, Uwe Schedler, H. Jehle, Ute Resch‐Genger · 2015 · Analytical and Bioanalytical Chemistry
  99. Identifying Rare Events in Rare Diseases
    Edward F. Attiyeh, John M. Maris · 2014 · Clinical Cancer Research
  100. Combining DNA-microarray data in systemic lupus erythematosus
    Cornelis L. Verweij, Saskia Vosslamber · 2011 · Genome Medicine